Correction: Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-κB signaling pathway of osteoclasts

Read full text
Authors: Tao Li, Guangyao Jiang, Xuantao Hu, Daishui Yang, Tingting Tan, Zhi Gao, Zhaoqi Chen, Cheng Xiang, shizhen Li, Zhengxiao Ouyang, Xuezhen Guo
Cited by: 1

Abstract

Correction on: Li T, Jiang G, Hu X, Yang D, Tan T, Gao Z, Chen Z, Xiang C, Li S, Ouyang Z, and Guo X (2021) Wrong content There was a mistake in Figure1B as published. Specifically, the images for the control and 31.25 μM in the BMMs group and the 125 μM splenocytes group were incorrectly selected during figure preparation. The affected images have been replaced with the correct representative images from the original experiments. The corrected Figure 1B appears below.Frontiers Media SA 3These changes do not affect the scientific conclusions of the article in any way. The authors apologize for this error and any confusion it may have caused.The original version of this article has been updated.If you would like to request a correction for a reason not seen here, please contact the journal's editorial office.

Fields of Study & Subjects

Pomegranate: compositions and health benefits Bone Metabolism and Diseases Bone health and treatments

Publication details

Journal / source
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Volume
17
Pages
1678237–1678237
Publication date
19 January 2026
Language
EN